IRIDEX Corporation joins Sidoti Year-End Virtual Investor Conference

IRIDEX Corporation filed a current report to highlight its participation in the Sidoti Year-End Virtual Investor Conference on December 11, 2025.

Rhea-AI Filing Summary

IRIDEX Corporation filed a current report to highlight its participation in the Sidoti Year-End Virtual Investor Conference on December 11, 2025. A live webcast of the presentation is scheduled to begin at 10:45 a.m. Eastern Time and will be available, along with an archived version, in the investors section of the company’s website at www.IRIDEX.com.

The company is also making available a set of presentation materials as Exhibit 99.1. These materials are being furnished, not filed, under Regulation FD, meaning they are shared for information purposes and are not treated as part of the company’s formal financial reporting under Section 18 of the Exchange Act.

8-K Event Classification

Item 7.01 — Regulation FD Disclosure

1 item

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did IRIDEX Corporation (IRIX) announce in this 8-K filing?

IRIDEX Corporation announced that it is participating in the Sidoti Year-End Virtual Investor Conference on December 11, 2025, and is making related investor presentation materials available as Exhibit 99.1.

When is IRIDEX (IRIX) presenting at the Sidoti Year-End Virtual Investor Conference?

IRIDEX is presenting at the Sidoti Year-End Virtual Investor Conference on December 11, 2025, with a live webcast scheduled to begin at 10:45 a.m. Eastern Time.

How can investors access IRIDEX’s Sidoti conference webcast?

Investors can access the live and archived webcast of IRIDEX’s presentation through the investors section of the company’s website at www.IRIDEX.com.

What is included in Exhibit 99.1 for IRIDEX (IRIX)?

Exhibit 99.1 consists of presentation materials that IRIDEX is using in connection with its appearance at the Sidoti Year-End Virtual Investor Conference.

Are the IRIDEX (IRIX) presentation materials considered filed financial information?

No. The presentation materials in Exhibit 99.1 are being furnished under Item 7.01 of Regulation FD and are not deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934.

Is IRIDEX obligated to update the Sidoti conference presentation?

IRIDEX states that it is not undertaking to update the presentation materials included in Exhibit 99.1.

Who signed the IRIDEX (IRIX) 8-K related to the Sidoti conference?

The report was signed on behalf of IRIDEX Corporation by Patrick Mercer, the company’s Chief Executive Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/11/2025 - 10:16 AM Learn about SEC filing dates

false000100604500010060452025-12-112025-12-11

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 8-K CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	December 11, 2025
(Date of Report (date of earliest event reported)
IRIDEX CORPORATION
(Exact name of registrant as specified in its charter)
Delaware		000-27598	77-0210467
(State or other jurisdiction of incorporation or organization)		(Commission File Number)	(I.R.S. Employer Identification Number)
1212 Terra Bella Avenue Mountain View, California 94043
(Address of principal executive offices, including zip code)
(650) 940-4700
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of Class		Trading Symbol		Name of Exchange on Which Registered
Common Stock, par value $0.01 per share		IRIX		Nasdaq Capital Market

Item 7.01. Regulation FD Disclosure.

As previously announced, IRIDEX Corporation (the “Company”) is participating in the Sidoti Year-End Virtual Investor Conference to be held on December 11, 2025.A live webcast of the event will begin at 10:45 a.m. ET and will be accessible at that time and as an archived webcast on the investors section of the Company’s website at www.IRIDEX.com.

The Company is also furnishing presentation materials included as Exhibit 99.1 to this report pursuant to Item 7.01 of Form 8-K. The Company is not undertaking to update this presentation. The information in this report (including Exhibits 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This report will not be deemed an admission as to the materiality of any information herein (including Exhibits 99.1).

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
99.1		Presentation Materials.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

-2-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			IRIDEX CORPORATION
	By:		/s/PATRICK MERCER
			Patrick Mercer
			Chief Executive Officer
Date: December 11, 2025

-3-